Rehmann Capital Advisory Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$450 Hold
13
﹤0.01% 1629
2019
Q2
$411 Hold
13
﹤0.01% 1994
2019
Q1
$388 Sell
13
-72
-85% -$2.06K ﹤0.01% 2019
2018
Q4
$2.62K Sell
85
-53
-38% -$1.93K ﹤0.01% 1392
2018
Q3
$5.23K Buy
138
+19
+16% +$719 ﹤0.01% 1549
2018
Q2
$4.57K Sell
119
-33
-22% -$1.11K ﹤0.01% 1567
2018
Q1
$5K Buy
+152
New +$5.83K ﹤0.01% 1527

Other funds holding PBH

Rehmann Capital Advisory Group's PBH Position: Q3 2019 in Review

Rehmann Capital Advisory Group held its Prestige Consumer Healthcare (PBH) position steady in Q3 2019 at 13 shares worth $450. The position accounts for ﹤0.01% of the portfolio, ranked #1629.

Rehmann Capital Advisory Group first reported a position in PBH in Q1 2018 and has held it in 7 quarters since. The position peaked at $5.23K in Q3 2018. 230 funds tracked by Wall St. Rank hold PBH as of Q3 2019.

  • Rehmann Capital Advisory Group held 13 shares of Prestige Consumer Healthcare worth $450 as of Q3 2019.
  • Rehmann Capital Advisory Group left its Prestige Consumer Healthcare share count unchanged in Q3 2019.
  • Prestige Consumer Healthcare made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #1629 holding.
  • Rehmann Capital Advisory Group first reported a position in Prestige Consumer Healthcare in Q1 2018 and has held it in 7 quarters since.
  • Rehmann Capital Advisory Group's Prestige Consumer Healthcare position peaked at $5.23K in Q3 2018.
  • 230 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.